{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:09:27Z","timestamp":1777388967233,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T00:00:00Z","timestamp":1428364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jacc.2015.03.549","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T18:16:41Z","timestamp":1432577801000},"page":"2314-2327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Reducing In-Stent Restenosis"],"prefix":"10.1016","volume":"65","author":[{"given":"Robert A.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crawford A.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise A.","family":"Diver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel S.","family":"Dakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin W.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"McClure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith E.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith M.","family":"Channon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith G.","family":"Oldroyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew H.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.03.549_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A\u00a0comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group","volume":"331","author":"Serruys","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.549_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.549_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa025142","article-title":"A\u00a0comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction","volume":"349","author":"Andersen","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.549_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJMra051091","article-title":"Coronary-artery\u00a0stents","volume":"354","author":"Serruys","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.03.549_bib5","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/S0140-6736(08)60922-8","article-title":"Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis","volume":"371","author":"Bavry","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.03.549_bib6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"McFadden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.03.549_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.549_bib8","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1161\/CIRCULATIONAHA.110.000901","article-title":"Long-term (>10 years) clinical outcomes of first-in-man biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents","volume":"125","author":"Nishio","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.03.549_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcin.2014.01.165","article-title":"ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance","volume":"7","author":"Mattesini","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2015.03.549_bib10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/CIRCRESAHA.111.247445","article-title":"MicroRNAs in vascular and metabolic disease","volume":"110","author":"Zampetaki","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2015.03.549_bib11","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/cvr\/cvr299","article-title":"MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling","volume":"93","author":"McDonald","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2015.03.549_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2015.03.549_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.jacc.2015.03.549_bib14","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1172\/JCI59327","article-title":"MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death","volume":"122","author":"Aurora","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2015.03.549_bib15","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI70577","article-title":"Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy","volume":"124","author":"Bang","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2015.03.549_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1172\/JCI200420176","article-title":"Bone marrow-derived immune cells regulate vascular disease through a p27(Kip1)-dependent mechanism","volume":"114","author":"Boehm","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2015.03.549_bib17","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/01.CIR.102.14.1697","article-title":"Direct evidence for cytokine involvement in neointimal hyperplasia","volume":"102","author":"Rectenwald","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.03.549_bib18","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2353\/ajpath.2006.051054","article-title":"Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice","volume":"168","author":"Chamberlain","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacc.2015.03.549_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.02.004","article-title":"Regulation of T lymphocyte activation by microRNA-21","volume":"59","author":"Wang","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jacc.2015.03.549_bib20","doi-asserted-by":"crossref","first-page":"e76217","DOI":"10.1371\/journal.pone.0076217","article-title":"Dual role of miR-21 in CD4+ T-cells: activation-induced miR-21 supports survival of memory T-cells and regulates CCR7 expression in naive T-cells","volume":"8","author":"Smigielska-Czepiel","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jacc.2015.03.549_bib21","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1038\/cddis.2014.47","article-title":"MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2","volume":"5","author":"Ruan","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jacc.2015.03.549_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00041433-199912000-00004","article-title":"Pathology of in-stent restenosis","volume":"10","author":"Virmani","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2015.03.549_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35154","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2015.03.549_bib24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.RES.83.11.1097","article-title":"Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells","volume":"83","author":"Marx","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2015.03.549_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/bbrc.1999.1968","article-title":"Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells","volume":"267","author":"Shu","year":"2000","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.jacc.2015.03.549_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.ATV.21.3.365","article-title":"Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice","volume":"21","author":"Collins","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2015.03.549_bib27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI10370","article-title":"Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice","volume":"106","author":"Li","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2015.03.549_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jlb.62.3.349","article-title":"Expression and function of the early activation antigen CD69 in murine macrophages","volume":"62","author":"Marzio","year":"1997","journal-title":"J\u00a0Leukocyte Biol"},{"key":"10.1016\/j.jacc.2015.03.549_bib29","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/eji.1830220521","article-title":"Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM\/CD69 activation pathway","volume":"22","author":"Santis","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jacc.2015.03.549_bib30","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.106.141986","article-title":"MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation","volume":"100","author":"Ji","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2015.03.549_bib31","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1161\/ATVBAHA.111.229559","article-title":"MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities","volume":"31","author":"Wang","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2015.03.549_bib32","doi-asserted-by":"crossref","first-page":"122ra22","DOI":"10.1126\/scitranslmed.3003441","article-title":"MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion","volume":"4","author":"Maegdefessel","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacc.2015.03.549_bib33","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/eurheartj\/eht105","article-title":"miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation","volume":"34","author":"McDonald","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.03.549_bib34","doi-asserted-by":"crossref","first-page":"C1481","DOI":"10.1152\/ajpcell.00413.2009","article-title":"An essential role of PDCD4 in vascular smooth muscle cell apoptosis and proliferation: implications for vascular disease","volume":"298","author":"Liu","year":"2010","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715016496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715016496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T14:14:43Z","timestamp":1566742483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109715016496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":34,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0735109715016496"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.03.549","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing In-Stent Restenosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.03.549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 The Authors. Published by Elsevier Inc. on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}